In February 2017, a class-action lawsuit was filed against Quincy Bioscience for allegedly deceptively marketing Prevagen dietary supplements as clinically shown to improve memory and provide other cognitive benefits when such claims are false. (Karathanos et al v. Quincy Bioscience Holding Company, Inc. et al, Case No. 17-cv-1091, E. D. NY.)
For more information about the marketing of Prevagen and TINA.org’s coverage of the product, click here.
The Class-Action Tracker is intended to notify consumers about false advertising class-action lawsuits filed around the country, but does not necessarily reflect TINA.org’s opinion with respect to the lawsuits or disposition of the cases